10x Genomics (TXG) Stock: Buy, Sell, or Hold?
TXG - 10x Genomics, Inc. Class A Common Stock
$82.80
-0.82 (-0.98%)
▼
5d:
+18.71%
30d:
-8.37%
90d:
+75.16%
HOLD
MODERATE Confidence
Analysis Updated: Oct 29, 2026 12:00 AM ET
Earnings: Nov 05, 2026
6d
Get Alerted When TXG Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: TXG trades at premium valuation expecting 80.4% growth. Hold existing positions but don't chase. Wait for better entry.
📊 HOLD: TXG trades at premium valuation expecting 80.4% growth. Hold existing positions but don't chase. Wait for better entry.
In-depth Analysis How we analyze
Valuation Analysis: TXG is currently trading at $82.80, which is considered fair relative to its 30-day fair value range of $71.91 to $87.14. From a valuation perspective, the stock is trading at a premium (Forward PE: 1090.2) compared to its historical average (185.8). At these levels, the market is pricing in 80.4% annual earnings growth. This is a high bar to clear, indicating the stock may be priced for perfection.
Technical Outlook: Technically, TXG is in a strong uptrend. Immediate support is located at $67.25, while resistance sits at $87.82.
Market Sentiment: The stock scores a mixed 43/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, TXG is in a strong uptrend. Immediate support is located at $67.25, while resistance sits at $87.82.
Market Sentiment: The stock scores a mixed 43/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$71.91 -
$87.14
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
60.5%
Protect Your Profits
Holding TXG? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (43/100)
- BULLISH: High volume confirmation
- BEARISH: Trading above Wall St target ($77.50)
- BEARISH: Market expects 80.4% growth - appears too optimistic based on history
- NEUTRAL: Bottoming setup forming (43/100) — watch for confirmation
Trading Range Analysis
30-Day Trading Range
$71.91 -
$87.14
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$67.25
Resistance Level
$87.82
Current Trend
Strong Uptrend
Technical data as of
Oct 28, 2026
Fundamental Context
Forward P/E (Next Year Est.)
1090.22
Wall Street Target
$77.50
(-7.3%)
Revenue Growth (YoY)
-12.7%
Profit Margin
-12.2%
Valuation Premium vs History
+80.4% premium
PE vs Historical
1090.2 vs 185.8
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+80.4%
(market-implied from PE analysis)
1-Year Target
$125.43
(+50%)
2-Year Target
$188.14
(+125%)
3-Year Target
$282.22
(+238%)
3-Yr Target (if PE normalizes)
(PE: 1090→186)
PE COMPRESSION
$48.10
(-43%)
Significant PE compression expected
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 1090.2, Growth: 109.0%)
$282.22
(+238%)
Base:
(SPY PE: 19.9, Growth: 109.0%)
$5.14
(-94%)
Bear:
(PE: 16.9, Growth: 109.0%)
$4.37
(-95%)
Share & Embed Analysis
Last updated: October 29, 2026 12:19 PM ET
Data refreshes hourly during market hours. Next update: 1:19 PM
Data refreshes hourly during market hours. Next update: 1:19 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TXG showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
29 analysts |
$96 | 51 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
28 analysts |
$119 | 55 HOLD |
|
EW
Edwards Lifesciences Corp |
STRONG BUY
30 analysts |
$101 | 43 HOLD |
|
SYK
Stryker Corporation |
STRONG BUY
29 analysts |
$363 | 38 SELL |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
22 analysts |
$83 | 31 SELL |
Advanced TXG Option Strategies
Professional options setups generated by AI based on today's TXG price and gamma walls.
